Lonza Signs Licensing and Supply Agreements with California Stem Cell

Lonza says it has entered into worldwide, exclusive licensing and supply agreements with California Stem Cell (Irvine, CA), a privately held company that manufactures high-purity human cells for drug discovery, predictive toxicology and clinical application. The Lonza-California Stem Cell collaboration will make novel pluripotent stem cell products readily available to researchers worldwide. “This partnership will address the evolving needs of the research community by making broadly available high purity, human pluripotent stem cell-derived cells and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers